ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
9
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,902
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
409O ‐ Larotrectinib efficacy and safety in TRK fusion cancer: an expanded clinical dataset showing consistency in an age and tumor agnostic approach
Author(s):
DSW Tan
,
UN Lassen
,
CM Albert
,
S Kummar
,
CM van Tilburg
,
SG DuBois
,
B Geoerger
,
L Mascarenhas
,
N Federman
,
A Basu-Mallick
Publication date:
2018
Journal:
Ann Oncol
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
1,902
Long-term control and safety of larotrectinib in a cohort of adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors
Authors:
S Perreault
,
A. Drilon
,
UN Lassen
…
Efficacy of Larotrectinib inTRKFusion-Positive Cancers in Adults and Children
Authors:
A. Drilon
,
Theodore Laetsch
,
S Kummar
…
FDA approves larotrectinib for solid tumors with NTRK gene fusions
Authors:
See all similar
Cited by
1
New clinical trial designs in the era of precision medicine
Authors:
Elena Garralda
,
Rodrigo Dienstmann
,
Alejandro Piris-Gimenez
…
See all cited by